Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 6

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Feb 14, 2026; 32(6): 115941
Published online Feb 14, 2026. doi: 10.3748/wjg.v32.i6.115941

Table 2 Previous treatment exposure in patients initiating filgotinib

Treatment	n (%)
Infliximab	77 (74.0)
Adalimumab	37 (35.6)
Golimumab	9 (8.7)
Vedolizumab	32 (30.8)
Ustekinumab	26 (25.0)
Tofacitinib	17 (16.3)
Maintenance of 5-ASA	83 (79.8)
Previous varicella zoster virus vaccination	56 (53.8)
Concomitant corticosteroids	35 (33.6)
Concomitant immunomodulators	11 (10.6)

Citation: Caballero-Mateos AM, Trigo-Salado C, Suárez-Toribio Á, Martín-Rodríguez MDM, Rodríguez-González FJ, Valdés-Delgado T, Pallarés-Manrique H, Trapero-Martínez AM, Olmedo-Martín R, Bailón-Gaona C, Benitez Cantero JM, Gros B, Sáez-Díaz A, Hernández-Martínez Á. Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study. World J Gastroenterol 2026; 32(6): 115941
URL: https://www.wjgnet.com/1007-9327/full/v32/i6/115941.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i6.115941

Caballero-Mateos AM, Trigo-Salado C, Suárez-Toribio Á, Martín-Rodríguez MDM, Rodríguez-González FJ, Valdés-Delgado T, Pallarés-Manrique H, Trapero-Martínez AM, Olmedo-Martín R, Bailón-Gaona C, Benitez Cantero JM, Gros B, Sáez-Díaz A, Hernández-Martínez Á. Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study. World J Gastroenterol 2026; 32(6): 115941 [PMID: 41695287 DOI: 10.3748/wjg.v32.i6.115941]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.